AU2001249649A1 - 16836, a novel human phospholipase c family member and uses thereof - Google Patents

16836, a novel human phospholipase c family member and uses thereof

Info

Publication number
AU2001249649A1
AU2001249649A1 AU2001249649A AU4964901A AU2001249649A1 AU 2001249649 A1 AU2001249649 A1 AU 2001249649A1 AU 2001249649 A AU2001249649 A AU 2001249649A AU 4964901 A AU4964901 A AU 4964901A AU 2001249649 A1 AU2001249649 A1 AU 2001249649A1
Authority
AU
Australia
Prior art keywords
nucleic acid
acid molecules
family member
expression vectors
novel human
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2001249649A
Inventor
John J. Hunter
Rachel E Meyers
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Millennium Pharmaceuticals Inc
Original Assignee
Millennium Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Millennium Pharmaceuticals Inc filed Critical Millennium Pharmaceuticals Inc
Publication of AU2001249649A1 publication Critical patent/AU2001249649A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14Hydrolases (3)
    • C12N9/16Hydrolases (3) acting on ester bonds (3.1)

Abstract

The invention provides isolated nucleic acids molecules, designated 16836 nucleic acid molecules, which encode novel phospholipase C members. The invention also provides antisense nucleic acid molecules, recombinant expression vectors containing 16836 nucleic acid molecules, host cells into which the expression vectors have been introduced, and nonhuman transgenic animals in which a 16836 gene has been introduced or disrupted. The invention still further provides isolated 16836 proteins, fusion proteins, antigenic peptides and anti-16836 antibodies. Diagnostic methods utilizing compositions of the invention are also provided.
AU2001249649A 2000-03-31 2001-03-30 16836, a novel human phospholipase c family member and uses thereof Abandoned AU2001249649A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US19392100P 2000-03-31 2000-03-31
US60193921 2000-03-31
PCT/US2001/010273 WO2001075121A2 (en) 2000-03-31 2001-03-30 16836, a human phospholipase c family member and uses thereof

Publications (1)

Publication Number Publication Date
AU2001249649A1 true AU2001249649A1 (en) 2001-10-15

Family

ID=22715571

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2001249649A Abandoned AU2001249649A1 (en) 2000-03-31 2001-03-30 16836, a novel human phospholipase c family member and uses thereof

Country Status (7)

Country Link
US (1) US20010039331A1 (en)
EP (1) EP1294899B3 (en)
AT (1) ATE433489T1 (en)
AU (1) AU2001249649A1 (en)
DE (1) DE60138952D1 (en)
ES (1) ES2328448T7 (en)
WO (1) WO2001075121A2 (en)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2001270599A1 (en) * 2000-06-29 2002-01-08 Bayer Aktiengesellschaft Regulation of human phospholipase c-like enzyme
US6818420B2 (en) 2002-02-27 2004-11-16 Biosource International, Inc. Methods of using FET labeled oligonucleotides that include a 3′-5′ exonuclease resistant quencher domain and compositions for practicing the same
JP2005519284A (en) * 2002-03-01 2005-06-30 アプレラ コーポレイション Determining the suitability of a set of chemical modifications for an amino acid chain
WO2004067571A1 (en) * 2003-01-30 2004-08-12 Wu, Mengchao Monoclonal antibody against human hepatoma and use thereof
US20050064436A1 (en) * 2003-09-24 2005-03-24 Barrett Michael T. Methods and compositions for identifying patient samples
JP6604544B2 (en) * 2013-06-16 2019-11-13 国立大学法人 東京医科歯科大学 Double-stranded antisense nucleic acid with exon skipping effect

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1995008624A1 (en) * 1993-09-24 1995-03-30 Shionogi & Co., Ltd. HUMAN PHOSPHOLIPASE C-α AND DNA SEQUENCE CODING FOR THE SAME
US5587306A (en) * 1995-04-10 1996-12-24 Incyte Pharmaceuticals, Inc. Phospholipase C homolog
AU6891098A (en) * 1997-04-10 1998-10-30 Genetics Institute Inc. Secreted expressed sequence tags (sests)
JP2002534055A (en) * 1998-05-14 2002-10-15 カイロン コーポレイション Human gene and gene expression product V
CA2383592A1 (en) * 1999-03-31 2000-10-05 Curagen Corporation 2384891 acids including open reading frames encoding polypeptides; orfx
EP1074617A3 (en) * 1999-07-29 2004-04-21 Research Association for Biotechnology Primers for synthesising full-length cDNA and their use

Also Published As

Publication number Publication date
WO2001075121A2 (en) 2001-10-11
US20010039331A1 (en) 2001-11-08
EP1294899A2 (en) 2003-03-26
ES2328448T7 (en) 2012-03-16
ATE433489T1 (en) 2009-06-15
WO2001075121A9 (en) 2002-05-30
EP1294899B1 (en) 2009-06-10
EP1294899B3 (en) 2011-07-06
ES2328448T3 (en) 2009-11-13
WO2001075121A3 (en) 2002-04-25
DE60138952D1 (en) 2011-04-28

Similar Documents

Publication Publication Date Title
WO2001090323A3 (en) 46638, a putative family member of human lipoxygenase
WO2002006302A3 (en) 16816 and 16839, novel human phospholipase c molecules and uses therefor
AU2002211446A1 (en) 32144, a human fatty acid amide hydrolase and uses thereof
AU2001280639A1 (en) 13237,18480,2245 or 16228 human protein kinase molecules and uses therefor
WO2001075121A3 (en) 16836, a human phospholipase c family member and uses thereof
WO2002026803A3 (en) 22108 and 47916, novel human thioredoxin family members and uses thereof
WO2001094563A3 (en) 46980, a novel human neuroligin family member and uses thereof
WO2001075076A3 (en) 33167, a novel human hydrolase and uses therefor
WO2001094412A3 (en) 56201, a novel human sodium ion channel family member and uses thereof
WO2001066764A3 (en) 16835, a human phospholipase c and uses thereof
WO2001090145A3 (en) 57805, a human cadherin family member and uses thereof
WO2002020801A3 (en) 26199, 33530, 33949, 47148, 50226, and 58764, human transferase family members and uses therefor
WO2002038773A3 (en) A human phospholipase c and uses thereof
WO2001073051A3 (en) 46743 and 27417, novel human acyltransferase family members and uses therefor
WO2002050256A8 (en) 53010, a human carboxylesterase family member and uses thereof
WO2002029037A3 (en) 57800, a novel human cadherin and uses therefor
AU2001285204A1 (en) Atcr-1, a human acyltransferase and uses thereof
AU2002352068A1 (en) 2150, a human protein kinase family member and uses therefor
WO2002010401A3 (en) 18431 and 32374, human protein kinase family members and uses therefor
WO2002051991A3 (en) 17903, a human aminopeptidase and uses therefor
WO2002008394A3 (en) 23430, a novel human ubiquitin hydrolase family member and uses therefor
WO2002016603A3 (en) 23228, a novel human tetraspanin family member and uses thereof
WO2002016582A3 (en) Human sodium-sugar symporter family member and uses thereof
WO2002008397A3 (en) A human atpase and uses therefor
WO2002026804A3 (en) 84241, a human ring finger family member and uses thereof